About Rare DiseasesRare Disease Wiki

Prader-Willi Syndrome (PWS)

Name of disease:

Prader-Willi Syndrome (PWS)

ICD-10 diagnosis code:

Q87.11

Causes:

  • Prader-Willi syndrome is caused by a genetic change in a particular region of chromosome number 15.
  • Most often, part of the chromosome 15 that was inherited from the person’s father is missing or deleted in this critical region. This small deletion occurs in approximately 60% of cases and usually is not detectable with routine genetic analysis such as amniocentesis.
  • Another 35-40% of cases occur when an individual inherits two chromosome 15s from their mother and none from their father. This scenario is termed maternal uniparental disomy (UPD).
  • In a very small percentage of cases (1-3%), a small mutation in the Prader-Willi region causes the paternal chromosome 15 genetic material (although present) to be inactive.

Mode of inheritance:

  • Deletion and UPD are random occurrences and generally are not associated with an increased risk of recurrence in future pregnancies.
  • In the case of an imprinting mutation, Prader-Willi syndrome can reoccur within a family.

Prevalence:

1 in every 15,000 to 30,000 live births

Diagnosis:

  • A suspected diagnosis of PWS is usually made by a physician based on clinical symptoms.
  • The diagnosis is confirmed by a blood test. A “methylation analysis” can detect >99% of cases, including all of the major genetic subtypes of PWS (deletion, uniparental disomy, or imprinting mutation).
  • A “FISH” (fluorescent in-situ hybridisation) test will identify those patients with PWS due to a deletion, but it will not identify those who have Prader-Willi syndrome by “UPD” (uniparental disomy) or an imprinting error.

Age of onset:

Antenatal, neonatal

Common signs and symptoms:

  • An excessive appetite and overeating which can easily lead to dangerous weight gain
  • Restricted growth (children are much shorter than average)
  • Floppiness caused by weak muscles (hypotonia)
  • Learning difficulties
  • Lack of sexual development
  • Behavioural challenges such as emotional outbursts and physical aggression

Available treatment (medicinal and non-medicinal):

  • Use of special nipples or tubes for feeding difficulties
  • Strict supervision of daily food intake to prevent rapid weight gain
  • Growth Hormone (GH) therapy to increase height, lean body mass, and enhance mobility; decrease fat mass; and improve movement and flexibility
  • Treatment of eye problems by a paediatric ophthalmologist
  • Treatment of curvature of the spine by an orthopaedist
  • Sleep studies and treatment to help improve the quality of sleep
  • Physical therapy to increase muscular strength, achieve developmental milestones, and build lean body mass
  • Behavioural therapy to control emotions
  • Medications, especially serotonin reuptake inhibitors (SRIs), may reduce obsessive-compulsive symptoms. SRIs also may help manage psychosis.
  • Early interventions / Special needs programmes
  • Sex hormone treatments and/or corrective surgery to treat small genitals (penis, scrotum, clitoris)
  • Replacement of sex hormones during puberty may result in the development of adequate secondary sex characteristics (e.g., breasts, pubic hair, a deeper voice)
  • Placement in group homes during adulthood

Disease management tips:

  • Maintain a daily personal care routine with reminders from caretakers
  • Shower or wash daily, avoid baths
  • Encourage and praise patient’s good manners by caretakers

References:

Other useful websites: